Marshall Wace LLP boosted its position in Herbalife Ltd. (NYSE:HLF - Free Report) by 83.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,444,343 shares of the company's stock after purchasing an additional 658,536 shares during the quarter. Marshall Wace LLP owned about 1.43% of Herbalife worth $9,663,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quadrant Capital Group LLC raised its position in shares of Herbalife by 641.5% in the fourth quarter. Quadrant Capital Group LLC now owns 4,293 shares of the company's stock valued at $29,000 after buying an additional 3,714 shares during the last quarter. R Squared Ltd acquired a new position in Herbalife in the 4th quarter valued at $63,000. Van ECK Associates Corp lifted its stake in shares of Herbalife by 110.4% during the 4th quarter. Van ECK Associates Corp now owns 10,526 shares of the company's stock worth $70,000 after purchasing an additional 5,524 shares during the period. Headlands Technologies LLC lifted its stake in shares of Herbalife by 12,307.6% during the 4th quarter. Headlands Technologies LLC now owns 11,415 shares of the company's stock worth $76,000 after purchasing an additional 11,323 shares during the period. Finally, Range Financial Group LLC acquired a new stake in shares of Herbalife during the fourth quarter worth $124,000.
Herbalife Stock Down 4.5 %
Shares of Herbalife stock traded down $0.31 during trading hours on Friday, hitting $6.65. The company's stock had a trading volume of 1,812,351 shares, compared to its average volume of 2,245,051. The business has a fifty day moving average of $7.79 and a 200 day moving average of $7.25. Herbalife Ltd. has a 1-year low of $5.04 and a 1-year high of $12.79. The company has a market capitalization of $673.92 million, a PE ratio of 2.67, a P/E/G ratio of 0.29 and a beta of 1.02.
Herbalife (NYSE:HLF - Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.08 by $0.28. Herbalife had a negative return on equity of 20.78% and a net margin of 5.09%. The company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.19 billion. On average, sell-side analysts anticipate that Herbalife Ltd. will post 1.57 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Herbalife news, Director Juan Miguel Mendoza bought 5,000 shares of the stock in a transaction dated Thursday, February 27th. The stock was bought at an average cost of $8.25 per share, for a total transaction of $41,250.00. Following the completion of the purchase, the director now directly owns 132,500 shares of the company's stock, valued at approximately $1,093,125. The trade was a 3.92 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.73% of the stock is currently owned by company insiders.
Analyst Ratings Changes
A number of equities analysts have weighed in on the stock. DA Davidson upgraded shares of Herbalife from a "neutral" rating to a "buy" rating and lifted their price target for the company from $7.50 to $14.00 in a report on Friday, March 21st. StockNews.com cut Herbalife from a "strong-buy" rating to a "buy" rating in a report on Friday, April 18th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, Herbalife presently has an average rating of "Moderate Buy" and a consensus target price of $12.00.
View Our Latest Analysis on HLF
Herbalife Profile
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
See Also
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
